Plasma lipoproteins and coronary arteriography in subjects in the program on the surgical control of the hyperlipidemias. Preliminary report

Richard B. Moore, John M. Long, John P. Matts, Kurt Amplatz, Richard L. Varco, Henry Buchwald

Research output: Contribution to journalArticlepeer-review

27 Scopus citations


Coronary arteriographic findings, plasma lipid and lipoprotein levels, and cigarette smoking history are reported for the first 101 male post myocardial infarction survivors who have been entered into the POSCH clinical trial. Estimates of the extent of stenosis in the major coronary arteries were made using 4 models ranging from a simple determination of the number of the 3 major vessels having significant (i.e. 50% or greater stenosis) disease to more complex methods of determining overall extent of disease in 14 major segments of the coronary arteries. Age was shown to be an important factor in the extent of vessel disease. When controlling for age, plasma cholesterol and LDL-cholesterol levels were shown to be related to the extent of disease, especially in Type II hyperlipoproteinemia subjects. Multiple linear regression analysis demonstrated that age and LDL-cholesterol had positive associations and HDL-cholesterol had an inverse association with the coronary artery disease indices. In this comparatively "healthy" subgroup of the overall population of first MI survivors the major CHD risk factors are limited to plasma lipids and cigarette smoking. This preliminary report of 10% of the recruitment objective of the project supports the currently held views of the lipid-atherosclerosis hypothesis regarding the effects of age, total plasma cholesterol, LDL-cholesterol, and HDL-cholesterol on the extent of coronary atherosclerotic plaques, as determined by coronary arteriography.

Original languageEnglish (US)
Pages (from-to)101-119
Number of pages19
Issue number2
StatePublished - Feb 1979

Bibliographical note

Funding Information:
Supported by NHLI Grant No. Hl-15625. * Program On The Surgical Control Of The Hyperlipidemias. Members of the POSCH Clinical Trial Study Group are: Henry Bucnwald, M.D., Ph.D. Wilfrido R. Castenada-Zuniga, Richard L. Varco, M.D.. Ph.D. Gustave Formanek, M.D. Richard B. Moore, M.D. Jane Speech, M.S. John M. Long, Ed.D. Sung Woo Kim. MS. Kurt Amplatz. M.D. Christine M. Windler, M.P.H. Gilbert S. Campbell, M.D. Joseph R. Brashear, B.A. Malcolm B. Pearce, M.D. Betty Hansen. R.N. Manfred D. Morris. Ph.D. Jean Rindahl, R.N. John P. Matts, Ph.D. Bonnie Kuhn, R.N. Naip Tuna, M.D. Becky Dunn. R.N. John B. McMullen, Richard L. Straumann, B.A.S.


  • Arteriography
  • Atherosclerosis
  • Coronary
  • Lipids/lipoproteins
  • Plasma


Dive into the research topics of 'Plasma lipoproteins and coronary arteriography in subjects in the program on the surgical control of the hyperlipidemias. Preliminary report'. Together they form a unique fingerprint.

Cite this